Drug intelligence / Profile preview

7.5% hypertonic saline

Development stage
Unknown
Lead developer
Aristotle University of Thessaloniki
Modality
Small Molecules
Administration
Intravenous
01

Overview

7.5% hypertonic saline is a concentrated sodium chloride solution used as a hyperosmolar therapy to manage brain edema and intracranial hypertension. It works by increasing the osmolarity of the intravascular compartment, creating an osmotic gradient that draws water out of the brain's intracellular and interstitial spaces across an intact blood-brain barrier. This reduction in brain water content leads to decreased intracranial pressure and improved brain relaxation during neurosurgical procedures such as supratentorial craniotomies. Unlike mannitol, 7.5% NaCl does not typically cause significant osmotic diuresis and may provide more sustained intracranial pressure control and favorable hemodynamic effects, such as increased cardiac output through vasodilation. This specific concentration was evaluated in a Phase 4 clinical trial by the Aristotle University of Thessaloniki to compare its effects on cerebral metabolism and oxygenation against 20% mannitol.

Other names
NaCl 7.5%7.5% NaClHypertonic saline 7.5%Sodium chloride 7.5%

Beyond the preview

Go deeper on 7.5% hypertonic saline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 7.5% hypertonic saline.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call